Northern Trust Corp Oric Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 353,341 shares of ORIC stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

353,341

Previous 353,197 0.04%

Holding current value

$2.5 Million

Previous $3.25 Million 49.52%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.04 - $16.03 $1,157 - $2,308	144 Added 0.04%	353,341 $4.86 Million
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $55,706 - $97,100	10,297 Added 3.0%	353,197 $3.25 Million
Q3 2023 Nov 13, 2023	BUY	$6.05 - $9.28 $30,062 - $46,112	4,969 Added 1.47%	342,900 $2.07 Million
Q2 2023 Aug 11, 2023	BUY	$4.95 - $8.4 $1.31 Million - $2.22 Million	264,208 Added 358.38%	337,931 $2.62 Million
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $3,369 - $5,339	791 Added 1.08%	73,723 $420,000

Q4 2022 Feb 13, 2023	SELL	$2.41 - $5.89 $739 - $1,808	-307 Reduced 0.42%	72,932 $429,000
Q3 2022 Nov 14, 2022	BUY	$3.28 - $5.24 $2,341 - $3,741	714 Added 0.98%	73,239 $234,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.07 $611,099 - $1.6 Million	-226,333 Reduced 75.73%	72,525 $325,000
Q1 2022 May 13, 2022	SELL	$4.54 - $16.1 $67,759 - $240,292	-14,925 Reduced 4.76%	298,858 $1.6 Million
Q4 2021 Feb 08, 2022	SELL	$12.01 - $20.3 $36,330 - $61,407	-3,025 Reduced 0.95%	313,783 $4.61 Million
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $618,780 - $981,486	38,917 Added 14.0%	316,808 $6.62 Million
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $818,717 - $1.19 Million	47,134 Added 20.43%	277,891 $4.92 Million
Q1 2021 May 12, 2021	SELL	$23.67 - $36.85 $148,884 - $231,786	-6,290 Reduced 2.65%	230,757 $5.65 Million
Q4 2020 Feb 11, 2021	BUY	$20.32 - $39.8 $2.66 Million - $5.22 Million	131,125 Added 123.79%	237,047 $8.02 Million
Q3 2020 Nov 16, 2020	SELL	$19.5 - $31.26 $96,135 - $154,111	-4,930 Reduced 4.45%	105,922 $2.65 Million
Q2 2020 Aug 14, 2020	BUY	$25.68 - $38.12 $2.85 Million - $4.23 Million	110,852 New	110,852 $3.74 Million

Others Institutions Holding ORIC

# of Institutions

113

Shares Held

59.3M

Call Options Held

302K

Put Options Held

7.7K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $280M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Oric Pharmaceuticals, Inc. Transaction History